Stage 1 invasive ductal breast cancer: nipple-preserving mastectomy with reconstruction
This breast cancer diagnosis at a glance
- Stage at diagnosis
- Stage I
- Subtype
- Invasive Ductal Carcinoma
- Biomarkers
- ER-positive; PR-positive; HER2-negative; Ki-67 28%
- Sex
- Female
- Treatment
- surgery, chemotherapy and hormone therapy
- Outcome
- Cancer-Free / NED
Treatment course, step by step
- Nipple-preserving mastectomy + sentinel node biopsy + immediate breast reconstruction using extended latissimus dorsi musculocutaneous flap
- frozen section and postoperative pathology showed clear margins; sentinel node biopsy showed no lymph node metastasis
- temporary superficial dermal nipple necrosis healed spontaneously
- adjuvant chemotherapy because of nuclear grade 3
- endocrine therapy; no recurrence at 20 months.
What happened, in summary
A 62-year-old woman was referred for treatment of right invasive ductal breast cancer located directly under the nipple-areolar complex or regional nodes. The tumor caused slight nipple retraction, but mammography, ultrasound, and MRI did not show direct cancer infiltration into the nipple-areolar complex, and there was no lymphadenopathy. The cancer was ER-positive, PR-positive, HER2-negative, with Ki-67 of 28%. Because preserving the nipple mattered strongly to the patient, the team attempted nipple-preserving mastectomy rather than removing the entire nipple-areolar complex. Surgery included nipple-preserving mastectomy, sentinel node biopsy, and immediate reconstruction using an extended latissimus dorsi musculocutaneous flap. The technique involved creating a thick skin flap, fully skeletonizing the mammary gland beneath the nipple, and resecting the nipple base as close as possible while maintaining the nipple-areolar complex. Frozen section and final pathology showed clear surgical margins, and sentinel node biopsy showed no lymph node metastasis. After surgery, the nipple developed temporary color change from superficial dermal necrosis, but this healed spontaneously without sequelae. Because the breast cancer was nuclear grade 3, she received adjuvant chemotherapy. She then continued endocrine therapy. At 20 months after surgery, she remained well without recurrence. Overall, this remained hormone receptor-positive, HER2-negative invasive ductal breast cancer without lymph-node or distant metastatic disease. The immediate reconstruction proceeded safely, and the nipple-preservation technique remained compatible with clear margins in this carefully selected tumor location. Imaging before surgery was central to that decision because it showed the tumor was under the nipple but had not directly infiltrated the nipple-areolar complex.
Where this story comes from
This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full
How we source and attribute stories Accuracy and limitations
Collections this story belongs to
- Stage 1 Breast Cancer 113 stories
- Chemotherapy for Stage 1 Breast Cancer 51 stories
- ER Positive Breast Cancer 242 stories
- Chemotherapy for ER Positive Breast Cancer 143 stories
- Chemotherapy for Breast Cancer 726 stories
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer